3.320USD0.00%Mkt Cap: 8.22M USDP/E: —Last update: 2026-06-01
Aclarion, Inc. operates as a healthcare technology company in the United States. It uses magnetic resonance spectroscopy (MRS) combined with proprietary signal-processing biomarkers to optimize clinical treatments. The c…
Industry Peers
Health Information ServicesIndicators:|
Key Statistics
Company
Market Cap8.22M USD
Enterprise Value-10.93M USD
Revenue (TTM)77.88K USD
Gross Profit6.83K USD
Net Income (TTM)-7.23M USD
Revenue/Share0.0770 USD
Last Price3.320 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees—
CountryUS
SectorHealthcare
IndustryHealth Information Services
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.60
PEG—
EV/EBITDA1.31
EV/Revenue-140.33
P/S103.70
P/B0.41
EPS (TTM)-5.63
EPS (Forward)-5.47
52W Range
2.34010% of range12.03
52W High12.03 USD
52W Low2.340 USD
Profitability
Gross Margin9.02%
Oper. Margin-14129.33%
EBITDA Margin0.00%
Profit Margin-9551.87%
ROE-56.36%
ROA-52.91%
Growth
Revenue Growth11.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-7.16M USD
CapEx (TTM)203.90K USD
FCF Margin-6235.17%
FCF Yield-59.05%
Net Debt-19.00M USD
Net Debt/EBITDA2.29
Balance Sheet
Debt/Equity—
Current Ratio19.65
Quick Ratio19.31
Book Value/Sh8.039 USD
Cash/Share7.719 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:27
Split DateMar 28, 2025
Analyst Consensus
Rating—
Target (Mean)7.000 USD
Target Range7.000 USD – 7.000 USD
# Analysts1
Ownership
Shares Out.2.46M
Float2.21M
Insiders10.56%
Institutions4.35%
Short Interest
Short Ratio1.8d
Short % Float8.06%
Short % Out.8.06%
Shares Short198.54K
Short (prev mo.)197.72K
Technical
SMA 503.289 (+0.9%)
SMA 2005.237 (-36.6%)
Beta—
S&P 52W Chg27.94%
Avg Vol (30d)106.95K
Avg Vol (10d)106.49K
Technical Indicators
RSI (14)53.3
MACD-0.0107
MACD Signal-0.0251
MACD Hist.+0.0145
BB Upper3.386 USD
BB Middle3.226 USD
BB Lower3.065 USD
BB Width9.95%
ATR (14)0.1765 USD
Vol Ratio (20d)1.47x